V

Viking Therapeutics

D
VKTX
USD
2.97
(4.5075%)
Market Closed
123,627.00
Volume
-0.95
EPS
-
Div Yield
-73.709670
P/E
7,629,426,332.00
Market Cap
Today
6.0200%
1 Week
-5.060%
1 Month
9.336%
6 Months
-13.492%
12 Months
566.602%
Year To Date
270.116%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CRBP
-0.59
(-3.0809%)
USD
I
ICPT
(%)
USD
G
GNFT
0.28
(5.045%)
USD
GILD
GILD
6.23
(6.7946%)
USD
A
ARWR
0.055
(0.2579%)
USD
GSK
GSK
0.89
(2.4881%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
AMGN
AMGN
0.28
(0.087%)
USD

Title:
Viking Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Do you need help or have a question?
Contact Us